Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 41,119 | 10,890 | 11,484 |
| Gross Profit | N/A | N/A | 41,119 | 10,890 | 11,484 |
| Operating Expenses | 14,202 | 12,433 | 9,754 | 14,787 | 14,998 |
| Operating Income | -14,202 | -12,433 | 31,365 | -3,897 | -3,514 |
| Other Income | 57 | 47 | 106 | 451 | 901 |
| Pre-tax Income | -14,145 | -12,386 | 31,471 | -3,446 | -2,613 |
| Income Tax | N/A | N/A | -73 | 0 | N/A |
| Net Income Continuous | -14,145 | -12,386 | 31,544 | -3,446 | -2,613 |
| Net Income | $-14,145 | $-12,386 | $31,544 | $-3,446 | $-2,613 |
| EPS Basic Total Ops | -2.17 | -1.89 | 4.90 | -0.56 | -0.42 |
| EPS Basic Continuous Ops | -2.18 | -1.91 | 4.90 | -0.54 | -0.41 |
| EPS Diluted Total Ops | -2.17 | -1.89 | 4.90 | -0.56 | -0.42 |
| EPS Diluted Continuous Ops | -2.18 | -1.91 | 4.88 | -0.54 | -0.41 |
| EBITDA(a) | $-14,157 | $-12,418 | $31,365 | $-3,775 | $-3,351 |